Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2018, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2018-11-13
DOI
10.1155/2018/5205126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity
- (2018) Lora J. Kasselman et al. ATHEROSCLEROSIS
- Gut microbiota in cardiovascular disease and heart failure
- (2018) Takeshi Kitai et al. CLINICAL SCIENCE
- Changes in Gut Microbiota–Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial
- (2018) Yoriko Heianza et al. DIABETES CARE
- The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease
- (2018) Stefanie Ascher et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Gut flora-dependent metabolite Trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress
- (2018) Yilang Ke et al. FREE RADICAL BIOLOGY AND MEDICINE
- Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
- (2018) Artur Nowiński et al. NUTRITION
- High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats
- (2018) Klaudia Bielinska et al. NUTRITION
- Gut microbiota derived metabolites in cardiovascular health and disease
- (2018) Zeneng Wang et al. Protein & Cell
- Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
- (2018) Jing Gao et al. Frontiers in Cellular and Infection Microbiology
- Gut microbiota and acute coronary syndromes: ready for use in the emergency room?
- (2017) Marius Trøseid EUROPEAN HEART JOURNAL
- Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis
- (2017) Gabriele Giacomo Schiattarella et al. EUROPEAN HEART JOURNAL
- The Microbiome and Risk for Obesity and Diabetes
- (2017) Anthony L. Komaroff JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The gut-blood barrier permeability – A new marker in cardiovascular and metabolic diseases?
- (2017) Marcin Ufnal et al. MEDICAL HYPOTHESES
- Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite
- (2017) Kinga Jaworska et al. PLoS One
- Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases
- (2017) Kimberley Lau et al. Nutrients
- Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies
- (2017) Yoriko Heianza et al. Journal of the American Heart Association
- Uncovering the trimethylamine-producing bacteria of the human gut microbiota
- (2017) Silke Rath et al. Microbiome
- Gut bacteria-derived molecules as mediators and markers in cardiovascular diseases. The role of the gut-blood barrier.
- (2017) Marcin Ufnal et al. Kardiologia Polska
- Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective
- (2017) Jun-Ling Han et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism
- (2016) Rima Obeid et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The gut microbiota: a key regulator of metabolic diseases
- (2016) Jin-Young Yang et al. BMB Reports
- Increased Trimethylamine N- Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus
- (2016) W. H. Wilson Tang et al. CLINICAL CHEMISTRY
- Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels
- (2016) M. Dambrova et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- The gut microbiota and metabolic disease: current understanding and future perspectives
- (2016) T. Arora et al. JOURNAL OF INTERNAL MEDICINE
- Resveratrol Attenuates Trimethylamine- N -Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
- (2016) Ming-liang Chen et al. mBio
- Impact of the gut microbiota on inflammation, obesity, and metabolic disease
- (2016) Claire L. Boulangé et al. Genome Medicine
- Trimethylamine N-Oxide: The Good, the Bad and the Unknown
- (2016) Manuel Velasquez et al. Toxins
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
- (2015) Caroline S. Fox et al. DIABETES CARE
- Gut microorganisms as promising targets for the management of type 2 diabetes
- (2015) Nathalie M. Delzenne et al. DIABETOLOGIA
- Role of the Gut Microbiome in Obesity and Diabetes Mellitus
- (2015) Gillian M. Barlow et al. NUTRITION IN CLINICAL PRACTICE
- Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
- (2015) Luca Miele et al. Current Cardiology Reports
- Probiotics as Complementary Treatment for Metabolic Disorders
- (2015) Mélanie Le Barz et al. Diabetes & Metabolism Journal
- Gut Microbiota and Metabolic Disorders
- (2015) Kyu Yeon Hur et al. Diabetes & Metabolism Journal
- Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions
- (2014) J. B. Halter et al. DIABETES
- Modulation of the Gut Microbiota by Nutrients with Prebiotic and Probiotic Properties
- (2014) Céline Druart et al. Advances in Nutrition
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation